Pharmaco - Press Releases

Date	Title	Company
10-Nov-2022	Invitation to MorphoSys’ Third Quarter and First Nine Months 2022 Results Conference Call on November 17, 2022	MorphoSys AG
10-Nov-2022	PharmaSGP Holding SE raises forecast for FY 2022	PharmaSGP Holding SE
10-Nov-2022	Heidelberg Pharma and Partner Magenta to Present Initial Clinical Data on their Antibody Drug Conjugates at the ASH Annual Meeting 2022	Heidelberg Pharma AG
10-Nov-2022	SOTIO Presents Preclinical Data from BOXR CAR-T Program and Trial Design of Phase 2 AURELIO-04 Study at SITC Annual Meeting	B3C newswire
10-Nov-2022	CureVac to Report Third Quarter and First Nine Months 2022 Financial Results and Business Updates on November 16, 2022	CureVac
10-Nov-2022	Novo Nordisk Foundation announces support for new open collaborative platform to accelerate the development of plant-based foods	Novo Nordisk
10-Nov-2022	Novo Holdings and Sound Bioventures launch Breye Therapeutics to develop novel oral therapies for ophthalmologic diseases	Novo Holdings
10-Nov-2022	Visionable and Brainomix announce strategic partnership to tackle “bottlenecks” in time-sensitive stroke care pathway	Visionable
10-Nov-2022	EnteroBiotix partners with Imperial College London to develop microbiome therapeutics	EnteroBiotix
10-Nov-2022	RHÖN-KLINIKUM AG closes first nine months of 2022 with revenue surplus	RHÖN-KLINIKUM Aktiengesellschaft
10-Nov-2022	Medios AG continues growth course in the first nine months of 2022 – guidance for the 2022 financial year confirmed	Medios AG
10-Nov-2022	APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill pipeline to achieve medium-term targets	APONTIS PHARMA AG
10-Nov-2022	Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil	Evolva Holding SA
10-Nov-2022	SYNLAB AG: SYNLAB reports strong underlying performance in 9M 2022, confirms 2022 guidance and releases 2023 guidance	SYNLAB AG
09-Nov-2022	Leva Clinic raises $3.5m to scale UK’s first digital chronic pain management platform	Leva Clinic
09-Nov-2022	Epigenomics AG reports financial results for the first nine months 2022	Epigenomics AG
09-Nov-2022	Evotec SE reports results for the first nine months 2022 and provides corporate update	Evotec SE
08-Nov-2022	UK MHRA expands Cosentyx® (secukinumab) licence for use in paediatric arthritic conditions	Novartis
08-Nov-2022	Envirotainer heavily invests and expands capacity, surpassing a billion doses per year to meet future need for temperature-controlled pharmaceutical shipping	Envirotainer
08-Nov-2022	EVERSANA® Named Great Place to Work Across Five Countries on Three Continents	EVERSANA®